Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Cancer Chemotherapy and Biological Response Modifiers|September 2, 2004
Mucins in gastrointestinal cancersMichael S Turner, John R McKolanis, Ramesh K Ramanathan, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 16, 2007
Incessant ovulation, mucin 1 immunity, and risk for ovarian cancerKathryn L Terry, Linda Titus-Ernstoff, John R McKolanis, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2005
Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancerDaniel W Cramer, Linda Titus-Ernstoff, John R McKolanis, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 27, 2010
Anti-MUC1 antibodies and ovarian cancer risk: prospective data from the Nurses' Health StudiesSimone P Pinheiro, Susan E Hankinson, Shelley S Tworoger, et al.Cancer Prevention Research (Philadelphia, Pa.)|December 19, 2012
MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility studyTakashi Kimura, John R McKolanis, Lynda A Dzubinski, et al.Cancer Causes & Control : CCC|June 19, 2010
Mumps and ovarian cancer: modern interpretation of an historic associationDaniel W Cramer, Allison F Vitonis, Simone P Pinheiro, et al.Cancer Therapy|January 9, 2009
A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumorsAndrew J Lepisto, Arthur J Moser, Herbert Zeh, et al.Pageof 1